Experience

MSD in the UK

• United Kingdom
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• UK Strategy Lead

  • Jul 2021 - Present

  Leading the MSD UK Strategy Office team of 12 delivering a strategic partnership internal ‘consulting’ model Leading the MSD UK Strategy Office team of 12 delivering a strategic partnership internal ‘consulting’ model



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director, Global Marketing and Strategy, HPV Vaccines

  • Apr 2019 - Jul 2021

  Director of global strategy, supply(capital expansion) and forecasting for the HPV franchiseSpecial assignment (3 months): Global Vaccine Confidence Data Strategy Lead

• Associate Director, Global Market Access

  • Oct 2017 - Apr 2019

  Global access leader for diabetes and vaccines

• General Management Acceleration Programme (GMAP), Senior Specialist, Stategy & Operations

  • Oct 2016 - Oct 2017

  Centre of Observational & Real World Evidence (CORE) Strategy Realization Lead Leading the socialization and realization of the CORE strategy map. The Strategy Map outlines how CORE will lead strategic value evidence generation and access strategy to optimize reimbursement and patient outcomes. Successfully leading the collaboration across CORE, MRL and GHH in the coordination and integration of the CORE Strategic workstreams to deliver key strategic projects to execute on CORE’s strategy. Providing project management support to the CORE strategic workstreams; Communications, Workforce of the Future, Customer Relevant Plans, Knowledge Management & Data Innovation. Collaborating with workstream leaders and teams to ensure full integration and execution. Project leader for the CORE valuation team with the objective of establishing a framework for generating effective, relevant and accurate outcomes that clearly demonstrate CORE’s impact and value to Merck overall.CORE Scorecard Lead Facilitated the 2016 Scorecard process to evaluate progress against 2016 strategy. Using the 2016 stakeholder results and qualitative feedback successfully facilitated the CORE leadership team’s 2016 performance assessment. Leading the development of the 2017 CORE Scorecard which translates CORE’s strategic objectives into initiatives that effectively execute against the organizations strategy. Collaborating across divisions to ensure the CORE scorecard and prioritization is aligned to MRL, GHH and Merck priorities. Guiding the leadership team’s strategy mobilization and full organization alignment through effective management and communication of strategic priorities.



MSD

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Merck General Management Acceleration Programme (GMAP), Senior Sepcialist Marketing

  • Aug 2015 - Sep 2016

  Keytruda Patient Support Programme (PSP) Project Lead Patient Support Programme (PSP) project lead with the objective of establishing MSD as an innovative and leading oncology company that delivers valuable solutions beyond the clinical efficacy of Keytruda. Gathered market and customer insight to inform a clear strategic direction and facilitated concept creation and detailed design. Presented the PSP strategy and design to senior stakeholders securing sponsorship and pilot status for Ireland. Project manager for the development and implementation stages working across functions and with external partners. Ensured all internal resources and suppliers were fully engaged and effectively managed compliance, spend and performance. Oversaw risk management ensuring controls were in place to mitigate internal and supplier related risks. Successfully launched the gold standard KeyCare Patient Support Programme in Ireland and transitioned the programme to Global Oncology IT for roll out in several other markets.Irish 2016 Distribution Review Project Manager Project Manager of the Irish 2016 Distribution Review team selected to identify opportunities to improve services and determine the distribution model for each channel that delivers the greatest value to MSD and its customers. Led the collaboration across Supply Chain, Procurement, Legal and Human Health leadership to deliver this project. Co-ordinated market intelligence and information gathering to inform the Request for Proposal (RFP) and benchmarked best practices, pricing and models across the local markets. Facilitated the cross-functional workshops to construct the distribution scenarios that provide the greatest flexibility based on end-customer needs. Negotiated an innovative solution delivering process improvements, increased flexibility and significant annual savings. This solution significantly advanced capabilities, achieving the best possible availability of medicine for Irish patients.

• Technical Specialist

  • Sep 2014 - Aug 2015

  Noxafil IV Value Chain Management Team (VCMT) Product Steward- Core member, focused on the integration and collaboration of value chain components in order to deliver the greatest value to the company while meeting customer needs. - Co-ordinated the End to End Technical Risk Assessment to identify, prioritise and mitigate risks at each manufacturing node.Posaconazole IV Integrated Development and Supply Team (IDST) Technical Lead-Core member of the Posaconazole IDST ensuring clear strategic objectives are developed and project plans are executed.- Co-ordinated and participated in individual working groups formed to develop, execute, and manage the cross-functional plans to achieve the deliverables.- Activities included managing customer complaints, monitoring and reporting process performance, supporting the ongoing filing and launch activities, responding to specific regulatory requests. Noxafil Technical Lead, Brinny- Project Manager of a 2015 priority one project: The Noxafil API Source Change- Core member of specially assembled Sterile IPT team dedicated to delivering commercial batches.- Technical representative on the priority one project to transition from manufacturing two batches per week to three.- Other responsibilities included the Continuous Process Verification (CPV) plan and reports, assisting in minor and major deviation investigations, continuous improvement. Container Closure Integrity (CCI) SME- Governance at Site Quality Council and responsible for ensuring metrics are defined, monitored and actions addressed. - Ensuring the system procedures were fully aligned and compliant.Additional Responsibilities- Permanent Inspection Readiness (PIR). Leading audit preparation including the lean activity of Gemba walks and meetings. Engaged in problem solving and preparation of responses during audits.

• Associate Specialist Engineering. Graduate Programme

  • Sep 2013 - Sep 2014

  Summer Operations Shutdown 2014-Core member of the Shutdown co-ordination team throughout the planning, scheduling and execution phases.-Planning phase: determined the scope of work, pre shutdown activities, resources and general logistics.-Scheduling phase: determined the order of work, responsibilities for each task and the workflow logistics.-Execution phase: co-ordinated the shutdown work on a daily basis. Ran cross functional meetings, cascaded information, co-ordinated contractors and problem solved on a timely basis.Laboratory Asset Management Program-Project lead on the implementation of an initiative to consolidate laboratory services. -Liased with equipment owners across several departments. Defined the scope and finalised the most strategic equipment listing for achieving resource and cost savings.-Worked with procurement to prepare a detailed Request for Proposal including a Service Level Agreement.-Analysed vendors proposals using specified selection criteria. This analysis included site visits and clarification meetings.-Implemented a solution that amalgamated the entire sites analytical equipment service programs under one centralised outsourced provider. This solution delivered significant cost and resource savings.Audit Support – Technical Review-Supported the technical review of fill weight process performance in preparation for a commercial FDA approval audit.-Responsible for data collection and review. Calculated the Process Capability Index, CpK, and analysed the results. -Responsible for analysing a number of Critical Quality Attributes (CQA’s) to demonstrate that all batches manufactured to date were comparable. Generated control charts using JMP statistical software for this analysis.



MSD

• Associate Technical Specialist, Sterile COE

  • Apr 2012 - Sep 2012

  6month Work Placement at MSD Brinny Technical Specialist, Sterile COE, Technical Services, MSD Brinny 1. Cleaning Verification - Prepared, executed and completed Cleaning Verification Protocols and Reports, ensuring compliance to all relevant Quality Standards and Regulatory requirements. - Prepared Cleaning and Decontamination Strategy Documents, assessing the worst case locations and determining residue limits as per regulations. - Arranged for swabbing and testing of all worst location equipment. 2. Biochemical Hold Time Model - Collected and reviewed historical hold time data from forty previous batches. - Investigated and analysed the existing model using the data collected. - Modified the existing model as per IFN specifications to propose a new hold time model. - Tested and analysed the accuracy and robustness of the new model. 3. Sampling, Testing and Shipping - Prepared the sampling plans for clinical and engineering batches. - Co-ordinated the sampling and testing both on and off site. - Scheduled and co-ordinated the shipment of clinical and engineering batch vials for testing. 4. Side Projects - Managed and ensured all batch equipment was available and fit for use. - Supported set up of the lyophiliser for engineering batches. - Part of the team who conducted a HAZOP for a new drug product.